You will be shown inclusion or exclusion criteria for a clinical trial. Given these criteria, your task is to extract all unique entities of the following types: ["Observation", "Condition", "Procedure", "Drug", "Temporal", "Multiplier", "Qualifier", "Negation", "ReferencePoint", "Scope", "Value", "Mood", "Device", "Visit", "Measurement", "Person"].

Please return the output as a JSON object of the format: {"Condition" : ["breast cancer", ...], "Device" : ["ports", ...], "Drug" : ["Atenolol", ...], "Measurement" : ["blood pressure", ...], "Mood" : ["suspected", ...], "Multiplier" : ["more than two", ...], "Negation" : ["no", ...], "Observation" : ["history", ...], "Person" : ["male", ...], "Procedure" : ["surgery", ...], "Qualifier" : ["severe", ...], "ReferencePoint" : ["enrollment", ...], "Scope" : ["infection", ...], "Temporal" : ["one day", ...], "Value" : ["50%", ...], "Visit" : ["ICU", ...]}. The keys should be entity types and values should be lists of extracted entities belonging to the corresponding type. If you cannot find entities belonging to a specific type, the value should be [].

Only output the JSON object and do not include any additional text.

Abstract:

Women of child-bearing potential, who are biologically able to conceive, not employing two forms of highly effective contraception or who are pregnant. 
Women who are breast-feeding 
Fertile males unwilling to use contraception 
Patients with brain metastases or any history of brain metastases 
Patients who have undergone major surgery (e.g., intra-thoracic, -abdominal, or -pelvic) </= 4 weeks prior to starting study treatment or who have not recovered from such therapy 
Patients with a history of pulmonary embolism, or untreated deep vein thrombosis within the past 6 months 
Impairment of gastrointestinal (GI) function or GI disease that may significantly alter the absorption of dovitinib 
The subject has had another active malignancy within the past 5 years except for cervical cancer in situ, in situ carcinoma of the bladder or non-melanoma carcinoma of the skin. 
Patients who have received the last administration of an anticancer therapy including chemotherapy, immunotherapy, hormonal therapy and monoclonal antibodies </= 2 weeks prior to starting the study drug, or who have not recovered from the side effects of such therapy 
Cirrhosis, chronic active hepatitis or chronic persistent hepatitis 
Patients who are currently receiving prasugrel 
No concurrent use of isoniazid, labetolol, trovafloxacin, tolcapone, and felbamate 
No concurrent use of other investigational drugs or antineoplastic therapies. 
Patients with impaired cardiac function or clinically significant cardiac diseases.
{"Condition": ["chronic persistent hepatitis", "brain metastases", "child-bearing potential", "recovered from the side effects of such therapy", "cardiac diseases", "in situ carcinoma of the bladder", "biologically able to conceive", "Fertile", "deep vein thrombosis", "Impairment of gastrointestinal (GI) function", "GI disease", "breast-feeding", "cervical cancer in situ", "chronic active hepatitis", "active malignancy", "pulmonary embolism", "recovered from such therapy", "non-melanoma carcinoma of the skin", "pregnant", "impaired cardiac function", "Cirrhosis"], "Device": ["highly effective contraception"], "Drug": ["isoniazid", "monoclonal antibodies", "tolcapone", "prasugrel", "trovafloxacin", "labetolol", "other investigational drugs", "felbamate"], "Measurement": [], "Mood": [], "Multiplier": ["two"], "Negation": ["except", "not", "No"], "Observation": ["history", "unwilling to use contraception"], "Person": ["Women", "males"], "Procedure": ["hormonal therapy", "antineoplastic therapies", "intra -pelvic", "intra -abdominal", "chemotherapy", "anticancer therapy", "immunotherapy", "intra-thoracic", "major surgery"], "Qualifier": ["untreated", "may significantly alter the absorption of dovitinib", "clinically significant"], "ReferencePoint": ["starting study treatment", "starting the study drug"], "Scope": ["isoniazid, labetolol, trovafloxacin, tolcapone, and felbamate", "Impairment of gastrointestinal (GI) function or GI disease", "chemotherapy, immunotherapy, hormonal therapy and monoclonal antibodies", "pulmonary embolism, or untreated deep vein thrombosis", "cervical cancer in situ, in situ carcinoma of the bladder or non-melanoma carcinoma of the skin", "not employing two forms of highly effective contraception or who are pregnant", "intra-thoracic, -abdominal, or -pelvic", "other investigational drugs or antineoplastic therapies", "Women of child-bearing potential, who are biologically able to conceive"], "Temporal": ["\u003c/= 2 weeks prior to starting the study drug", "within the past 6 months", "within the past 5 years"], "Value": ["\u003c/= 4 weeks prior to starting study treatment"], "Visit": []}